Top compounds associated with response to TMPO


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.25 5e-18
mRNA etoposide CTRPv2 pan-cancer AAC 0.25 7e-16
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.25 1e-15
mRNA Topotecan CTRPv2 pan-cancer AAC 0.24 3e-13
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.24 9e-13
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 1e-12
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 3e-12
mRNA barasertib CTRPv2 pan-cancer AAC 0.23 1e-11
mRNA Topotecan CCLE pan-cancer AAC 0.3 2e-11
mRNA SN-38 CTRPv2 pan-cancer AAC 0.25 3e-11
Download CSV